Mach Tomasz, Skwara Paweł, Biesiada Grazyna, Cieśla Andrzej, Macura Anna
Department of Gastroenterology, Jagiellonian University, Medical College, Crocow, Poland.
Med Sci Monit. 2007 Jan;13(1):CR14-9. Epub 2006 Dec 18.
HIV infection causes progressive immune defense system dysfunction, including the gastrointestinal (GI) tract. The aim of the study was to evaluate the morphological changes in the upper-GI tract mucosa in HIV-infected patients in relation to the degree of immunodeficiency, presence of H. pylori, fungal colonization, and antiretroviral treatment (HAART).
MATERIAL/METHODS: One hundred forty-six patients (94 HIV positive, 52 HIV negative) with dyspeptic symptoms were evaluated by upper GI endoscopy and biopsy. The HIV-infected were divided into two groups: 47 patients with CD4+ count >200/mm(3) and 47 with severe immunodeficiency (CD4+ count <200/mm(3)); 42 of the total patients were treated with HAART. Gastric biopsies for histopathology and urease test, esophageal swabs, and gastric aspirates for mycological evaluation were taken.
The HIV-infected patients with severe immunodeficiency had a lower prevalence of H. pylori infection and active chronic gastritis in the gastric antrum compared with the other HIV-infected patients and controls (H. pylori in 40%, 72%, and 69%, respectively; p<0.05). Mycotic esophagitis and mycotic colonization of the stomach were more frequent in patients with severe immunodeficiency. The prevalence of gastric mucosa changes was not different between the patients treated and not treated with HAART; H. pylori infection was less frequent in HIV-infected patients treated with HAART (p<0.05).
In severely immunodeficient patients with dyspeptic symptoms, the prevalence of H. pylori and active chronic gastritis in the gastric antrum is much lower than in HIV-negative patients. H. pylori infection is less frequent in patients treated with HAART.
HIV感染会导致进行性免疫防御系统功能障碍,包括胃肠道。本研究的目的是评估HIV感染患者上消化道黏膜的形态学变化,这些变化与免疫缺陷程度、幽门螺杆菌感染情况、真菌定植以及抗逆转录病毒治疗(HAART)之间的关系。
材料/方法:对146例有消化不良症状的患者(94例HIV阳性,52例HIV阴性)进行上消化道内镜检查和活检。将HIV感染者分为两组:47例CD4+细胞计数>200/mm³的患者和47例严重免疫缺陷(CD4+细胞计数<200/mm³)的患者;42例患者接受了HAART治疗。采集胃组织进行组织病理学和尿素酶试验、食管拭子以及胃抽吸物进行真菌学评估。
与其他HIV感染患者及对照组相比,严重免疫缺陷的HIV感染患者胃窦部幽门螺杆菌感染率和活动性慢性胃炎患病率较低(幽门螺杆菌感染率分别为40%、72%和69%;p<0.05)。严重免疫缺陷患者中霉菌性食管炎和胃真菌定植更为常见。接受HAART治疗和未接受HAART治疗的患者胃黏膜变化患病率无差异;接受HAART治疗的HIV感染患者幽门螺杆菌感染率较低(p<0.05)。
在有消化不良症状的严重免疫缺陷患者中,胃窦部幽门螺杆菌感染率和活动性慢性胃炎患病率远低于HIV阴性患者。接受HAART治疗的患者幽门螺杆菌感染率较低。